A conjugate of an oligosaccharide fragment of tumor-associated ganglioside antigen with hemocyanin is a prototype antitumor vaccine.
Stepanenko
R N
RN
Institute of Immunology, Federal Biomedical Agency, Kashirskoe sh. 24, korp. 2, Moscow, 115478 Russia.
Tsvetkov
Yu E
YE
Khatuntseva
E A
EA
L'vov
V L
VL
Vlasenko
R Ya
RY
Nifant'ev
N E
NE
Petrov
R V
RV
D000818:Animals; D000951:Antigens, Neoplasm / Q000737:chemistry*; D019496:Cancer Vaccines / Q000276:immunology*; D004797:Enzyme-Linked Immunosorbent Assay; D005679:G(M3) Ganglioside / Q000737:chemistry / Q000276:immunology*; D006433:Hemocyanins / Q000737:chemistry*; D051379:Mice; D008810:Mice, Inbred C57BL; D018074:Vaccines, Conjugate / Q000276:immunology*
D000951:Antigens, Neoplasm; D019496:Cancer Vaccines; D005679:G(M3) Ganglioside; D018074:Vaccines, Conjugate; D006433:Hemocyanins